We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

162 hedge funds and large institutions have $1.47B invested in Acorda Therapeutics in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 63 increasing their positions, 45 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

40% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 45

7% more funds holding

Funds holding: 152 → 162 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less capital invested

Capital invested by funds: $1.57B → $1.47B (-$95M)

38% less call options, than puts

Call options by funds: $2.85M | Put options by funds: $4.62M

Holders
162
Holders Change
+10
Holders Change %
+6.58%
% of All Funds
4.66%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
63
Reduced
45
Closed
15
Calls
$2.85M
Puts
$4.62M
Net Calls
-$1.77M
Net Calls Change
-$2.7M

Top Buyers

Rank Fund Capital Flow
1
BM
Bridger Management
New York
+$38.1M
2
Millennium Management
Millennium Management
New York
+$24M
3
Citadel Advisors
Citadel Advisors
Florida
+$19.2M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$15.4M
5
Jennison Associates
Jennison Associates
New York
+$14.3M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$35.7M
2
Goldman Sachs
Goldman Sachs
New York
-$29.3M
3
PHS
PFM Health Sciences
California
-$27.4M
4
TSW
Thompson Siegel & Walmsley
Virginia
-$22.3M
5
Invesco
Invesco
Georgia
-$13.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
American Century Companies
101
American Century Companies
Missouri
$1.09M -$36.7K -9 -3%
AIG
102
American International Group
New York
$1.08M – – –
Allianz Asset Management
103
Allianz Asset Management
Germany
$1.06M -$3.34M -819 -76%
ASRS
104
Arizona State Retirement System
Arizona
$1.06M +$81.6K +20 +8%
DC
105
Deere & Company
Illinois
$954K +$962K +236 New
CAM
106
Capstone Asset Management
Texas
$916K +$110K +27 +14%
New York State Teachers Retirement System (NYSTRS)
107
New York State Teachers Retirement System (NYSTRS)
New York
$903K – – –
Manulife (Manufacturers Life Insurance)
108
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$893K -$147K -36 -14%
OC
109
Oppenheimer & Co
New York
$885K +$893K +219 New
First Trust Advisors
110
First Trust Advisors
Illinois
$875K +$881K +216 New
Jacobs Levy Equity Management
111
Jacobs Levy Equity Management
New Jersey
$872K +$881K +216 New
PAM
112
Paradigm Asset Management
New York
$868K +$40.8K +10 +5%
JGC
113
J. Goldman & Co
New York
$843K -$4.06M -995 -83%
DekaBank Deutsche Girozentrale
114
DekaBank Deutsche Girozentrale
Germany
$806K -$40.8K -10 -5%
PPA
115
Parametric Portfolio Associates
Washington
$737K -$24.5K -6 -3%
Acadian Asset Management
116
Acadian Asset Management
Massachusetts
$728K +$734K +180 New
Bessemer Group
117
Bessemer Group
New Jersey
$714K – – –
ARTA
118
A.R.T. Advisors
New York
$675K +$681K +167 New
LSERS
119
Louisiana State Employees Retirement System
Louisiana
$651K +$8.15K +2 +1%
KeyBank National Association
120
KeyBank National Association
Ohio
$612K +$12.2K +3 +2%
Public Employees Retirement Association of Colorado
121
Public Employees Retirement Association of Colorado
Colorado
$525K – – –
TAM
122
Tocqueville Asset Management
New York
$506K +$32.6K +8 +7%
Citigroup
123
Citigroup
New York
$489K +$269K +66 +120%
SCA
124
Secor Capital Advisors
New York
$471K +$473K +116 New
USAA
125
United Services Automobile Association
Texas
$384K +$4.08K +1 +1%
3 4
5
6 7

ACOR Hedge Fund Activity: Q2 2014 in Review

162 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q2 2014, worth a combined $1.47B — down 6.1% from $1.57B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new ACOR positions and 15 closed out — a net gain of 11 holders — while 63 added to existing stakes and 45 trimmed.

The largest buyer was Bridger Management, opening a new position worth an estimated $38.1M. The largest seller was Franklin Resources, exiting entirely with an estimated $35.7M sold.

  • 162 institutional investors held Acorda Therapeutics (ACOR) as of Q2 2014, up from 152 in Q1 2014.
  • Funds reported $1.47B of Acorda Therapeutics stock for Q2 2014, down 6.1% quarter-over-quarter.
  • 26 funds opened new Acorda Therapeutics positions in Q2 2014 and 15 closed out, a net change of +11 holders.
  • The largest Acorda Therapeutics buyer in Q2 2014 was Bridger Management, an estimated $38.1M added.
  • The largest Acorda Therapeutics seller in Q2 2014 was Franklin Resources, an estimated $35.7M sold.

Based on aggregated 13F filings for Q2 2014.